These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17108988)

  • 1. Drug discovery and development for neglected parasitic diseases.
    Renslo AR; McKerrow JH
    Nat Chem Biol; 2006 Dec; 2(12):701-10. PubMed ID: 17108988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues in funding research and development of drugs for neglected tropical diseases.
    Oprea L; Braunack-Mayer A; Gericke CA
    J Med Ethics; 2009 May; 35(5):310-4. PubMed ID: 19407037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization.
    Savioli L; Engels D; Daumerie D; Jannin J; Alvar J; Asiedu K; Gastellu-Etchegorry M; Simarro P; Mariotti SP
    PLoS Med; 2006 Jun; 3(6):e283. PubMed ID: 16789805
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug development for neglected diseases - the trouble with FDA review vouchers.
    Kesselheim AS
    N Engl J Med; 2008 Nov; 359(19):1981-3. PubMed ID: 18987367
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomics, systems biology and drug development for infectious diseases.
    Sakata T; Winzeler EA
    Mol Biosyst; 2007 Dec; 3(12):841-8. PubMed ID: 18000561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filling the pipeline for neglected diseases: creation of a medicinal chemistry-centric international drug discovery institute [iDDi].
    Kozikowski AP; Reitz AB
    Drug Discov Today; 2008 Feb; 13(3-4):97-8. PubMed ID: 18275906
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing drugs for parasitic diseases of the developing world.
    McKerrow JH
    PLoS Med; 2005 Aug; 2(8):e210. PubMed ID: 16120007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A view on antimicrobial resistance in developing countries and responsible risk factors.
    Byarugaba DK
    Int J Antimicrob Agents; 2004 Aug; 24(2):105-10. PubMed ID: 15288307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
    Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
    Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing drugs for parasitic diseases.
    Andreopoulos S
    Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858
    [No Abstract]   [Full Text] [Related]  

  • 12. Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.
    Liotta F; Siekierka JJ
    Curr Opin Investig Drugs; 2010 Feb; 11(2):147-56. PubMed ID: 20112164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines against tropical parasitic diseases.
    Da'dara AA; Harn DA
    Expert Rev Vaccines; 2005 Aug; 4(4):575-89. PubMed ID: 16117713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-parasite relations and implications for control.
    Fenwick A
    Adv Parasitol; 2009; 68():247-61. PubMed ID: 19289197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and challenges in antiparasitic drug discovery.
    Pink R; Hudson A; Mouriès MA; Bendig M
    Nat Rev Drug Discov; 2005 Sep; 4(9):727-40. PubMed ID: 16138106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropical diseases: the burden and its implications.
    Bradley DJ
    Schweiz Med Wochenschr; 1997 Sep; 127(39):1592-7. PubMed ID: 9342805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening opportunities for new drugs against neglected diseases.
    Costi MP; Taramelli D; González-Pacanowska D
    ChemMedChem; 2008 Mar; 3(3):371-3. PubMed ID: 18324713
    [No Abstract]   [Full Text] [Related]  

  • 20. A theoretical flaw in the advance market commitment idea.
    Sonderholm J
    J Med Ethics; 2010 Jun; 36(6):339-43. PubMed ID: 20530089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.